You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股配售 | 永泰生物-B一手中簽率20%,公開認購259.58倍,國配7倍,有綠鞋
uSMART友信智投 07-09 11:28

uSMART友信智投7月9日消息,永泰生物製藥有限公司(06978)發佈《發售價及配發結果公告》。

【永泰生物-B的配售簡況】

1、發售價:11港元/股,為招股價(10.5-11港元)的上限

2、有效申購人數:94,738名(甲組:93,686名,乙組:1,052名)

3、中簽情況:一手中簽率20%,申購100手穩中1,甲組最多中3手,乙組穩中11手-71手

4、頂頭槌單:100張(每張中71手)

5、公開認購:259.58(甲組:232.44倍,乙組:286.72倍)

6、回撥情況:國配的40%股份回撥給公開,最終公開的比例為50%,國配的比例為50%(假設超額配股權未獲行使)

7、國際配售:7,合共204名承配人

8、基石投資者:鎖定28.1%的發行股份(假設超額配股權未獲行使)

9、超額配股權:國際發售中已超額分配15,000,000股股份,有綠鞋

10、關聯客戶:雷根國際證券的關連客戶Regan International Growth Fund SPC獲配售71,000股發售股份

11、穩定價格操作人:建銀國際

12、uSMART友信智投APP暗盤交易時段:7月9日16:15-18:30

【中簽率詳情】

甲組甲組最多中3

乙組穩中11-71

甲組:

一手中簽率20%

申購100手穩中1手

申購350手穩中2手

乙組:

申購500手穩中11手

申購600手穩中13手

……

申購5000手穩中71手

以下為中簽分配基準:

圖片來源:披露易

【基石投資者】

【關聯客戶】

點擊可閱讀《永泰生物-B的發售價及配發結果公告》PDF原文

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account